Stock screener

CLOV

Conviction 49HealthcareScan · Thu, Sep 24, 2026

Clover Health Investments, Corp. /De (CLOV) closed at $4.51 (-1.31%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 95, -16.6% from its 52-week high, +87.1% year to date. Sector: Healthcare · HOSPITAL & MEDICAL SERVICE PLANS.

CLOV$4.51-1.31%
ResistanceSupportVol 14Insider sell
63 bars
2
5
Vol MA14 4.57M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
CLOVER HEALTH INVESTMENTS, CORP. /DEHOSPITAL & MEDICAL SERVICE PLANSwww.cloverhealth.com ↗
Price4.51
Change-1.31%
Gap+0.77%
Rel volume0.89×
Avg volume4.25M
Avg $ vol19.22M
SMA 204.47
SMA 504.42
SMA 2003.28
Price vs 50+2.08%
Price vs 200+37.51%
MA stackbullish
50/200 cross—
Supertrendup · 4.34
RSI (14)51
MACD hist0.00
MACD cross—
Stoch %K / %D37 / 44
ADX (14)16
+DI / −DI25 / 20
RSI divergence—
MACD divergence—
ATR %4.91%
ADR %4.45%
52w high5.41
52w low1.70
From 52w high-16.64%
Above 52w low+165.29%
New 52w highNo
SqueezeOff
Bollinger width20.96%
%B0.54
Donchian pos36.62%
Donchian high5.19
Donchian low4.12
AVWAP (52w high)4.61
vs AVWAP high-2.17%
AVWAP (52w low)3.98
vs AVWAP low+13.41%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d0.89×
Avg vol (14d)4.57M
Avg vol (20d)4.25M
Avg $ vol (20d)19.22M
Market cap2.31B
RS Rating95 / 99
RS 3m (vs SPY)-17.93%
RS 6m (vs SPY)+130.98%
RS line new highNo
Trend template7/8
Technical rank90.3
1 week-0.66%
1 month+9.20%
3 months-13.44%
6 months+147.80%
1 year+38.77%
YTD+87.14%
P/E-26.99
P/B6.14
P/S1.20
P/FCF-33.47
EPS-0.4400
Div yield—
ROE-22.74%
ROA-11.88%
Debt/Eq0.00
Current1.50
EV/EBITDA-25.53
Gross margin13.37%
Net margin-4.45%
Rev growth40.34%
EPS growth-98.91%
Price target5.50
Target upside21.95%
Analyst ratingBuy
Institutional38.86%
Ent. value2.23B
Revenue743.17M
Net income28M
Gross profit81.21M
Free cash flow-68.98M
IndustryHOSPITAL & MEDICAL SERVICE PLANS
ExchangeNasdaq
Shares out430.97M
Employees724
ListedFri, Jan 8, 2021
Free float388.79M
Float %91.6%
Short interest23.68M
Days to cover6.9d
Short volume57.3%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.06
Last surprise—
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank90.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.19
Support4.08
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CLOV

All disclosures →
No recent disclosed trades by Congress in CLOV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CLOV · open-market 8 sells

InsiderSideShares
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER · Class A Common Stock · 2026-09-16
Sell3.17K
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-09-15
Sell9.27K
Soares Karen
Chief Legal Officer · Class A Common Stock · 2026-09-15
Sell6.85K
THORNTON JOSEPH CLAY
Interim CFO · Class A Common Stock · 2026-08-17
Sell17.77K
THORNTON JOSEPH CLAY
Interim CFO · Class A Common Stock · 2026-08-12
Grant54.35K
Soares Karen
Chief Legal Officer · Class A Common Stock · 2026-08-12
Grant108.69K
Toy Andrew
Chief Executive Officer · Class A Common Stock · 2026-08-10
Sell87.8K
Reynoso Jamie L.
CEO, Medicare Advantage · Class A Common Stock · 2026-07-17
Sell4.84K
THORNTON JOSEPH CLAY
Interim CFO · Class A Common Stock · 2026-07-15
Sell4.63K
Soares Karen
Chief Legal Officer · Class A Common Stock · 2026-07-15
Sell10.52K

SEC filings

EDGAR filings in CLOV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.